AstraZeneca opens global strategic R&D center in Cambridge, Massachusetts

Bitget2026/10/05 16:04

By:Bitget

AstraZeneca opened a new global strategic R&D center in Kendall Square, Cambridge, Massachusetts. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AstraZeneca plc published the original content used to generate this news brief on October 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Barrick Mining 3Q Copper Production 50,000 Tons >ABX.T

Dow Jones•2026/11/09 11:00

Barrick Mining 3Q EPS 80c >ABX.T

Dow Jones•2026/11/09 11:00

Nifty 50 Is Still Down 4.91% in 2026, So Why Does Citi See 13% Upside?

BeInCrypto•2026/11/09 08:24

US Dollar Index: Fed path and CPI focus – Deutsche Bank

FXStreet•2026/11/09 08:03